Biostar Pharmaceuticals, Inc. Announces Receipt of "Army New Drug Certificate" for Zushima Spray

Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that its Zushima Analgesic Spray ("Zushima spray") pain relief drug has received the "Army New Drug Certificate", which is registered with China military authorities as "Military Medicine Certificate # Z2012002". Zushima spray, which was developed in cooperation with Lanzhou Military Institute of Drugs and Instruments specifically for the needs of China's military, relieves pain and topical swelling, joint pain due to rheumatic conditions, and helps improve blood circulation near affected areas.